Minze Health

Minze Health is a Belgium-based (Antwerp) medical device and digital health company specializing in home-based diagnostics and digital therapeutics for lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), and overactive bladder (OAB). Founded in 2015 and ISO 13485:2016 certified, Minze develops integrated diagnostic and therapeutic solutions that combine in-clinic and home-based uroflowmetry, automated bladder diaries, and evidence-based digital behavioral therapy apps. The Homeflow platform enables smart uroflowmetry for home or in-clinic use with real-time web portal visualization, flow curve analysis, and longitudinal tracking. The Diary Pod is an automated sensor-based bladder diary that captures voiding patterns objectively, reducing patient recall bias. Clinical software includes web portals for providers and mobile apps delivering 13-week personalized therapy programs with lifestyle coaching and pelvic floor training. The company targets urology practices, hospitals, and health systems addressing the estimated 80 million US and 90 million EU adults with LUTS/BPH/OAB. Leadership includes executives with commercial and clinical backgrounds; the medical advisory board comprises senior urologists and urogynecologists from leading US, UK, Canadian, and European institutions. Minze is an AdvaMed member.